1. Home
  2. RDHL vs BNZI Comparison

RDHL vs BNZI Comparison

Compare RDHL & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • BNZI
  • Stock Information
  • Founded
  • RDHL 2009
  • BNZI 2016
  • Country
  • RDHL Israel
  • BNZI United States
  • Employees
  • RDHL N/A
  • BNZI N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • BNZI
  • Sector
  • RDHL Health Care
  • BNZI
  • Exchange
  • RDHL Nasdaq
  • BNZI Nasdaq
  • Market Cap
  • RDHL 8.2M
  • BNZI 8.9M
  • IPO Year
  • RDHL N/A
  • BNZI N/A
  • Fundamental
  • Price
  • RDHL $5.60
  • BNZI $1.56
  • Analyst Decision
  • RDHL
  • BNZI Strong Buy
  • Analyst Count
  • RDHL 0
  • BNZI 1
  • Target Price
  • RDHL N/A
  • BNZI $125.00
  • AVG Volume (30 Days)
  • RDHL 10.5K
  • BNZI 4.6M
  • Earning Date
  • RDHL 04-07-2025
  • BNZI 02-28-2025
  • Dividend Yield
  • RDHL N/A
  • BNZI N/A
  • EPS Growth
  • RDHL N/A
  • BNZI N/A
  • EPS
  • RDHL N/A
  • BNZI N/A
  • Revenue
  • RDHL $3,707,000.00
  • BNZI $4,310,782.00
  • Revenue This Year
  • RDHL $224.90
  • BNZI $5.58
  • Revenue Next Year
  • RDHL $82.69
  • BNZI $58.87
  • P/E Ratio
  • RDHL N/A
  • BNZI N/A
  • Revenue Growth
  • RDHL N/A
  • BNZI N/A
  • 52 Week Low
  • RDHL $5.41
  • BNZI $1.21
  • 52 Week High
  • RDHL $20.28
  • BNZI $71.15
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 38.40
  • BNZI 47.87
  • Support Level
  • RDHL $5.52
  • BNZI $1.48
  • Resistance Level
  • RDHL $6.26
  • BNZI $1.78
  • Average True Range (ATR)
  • RDHL 0.29
  • BNZI 0.27
  • MACD
  • RDHL -0.02
  • BNZI -0.01
  • Stochastic Oscillator
  • RDHL 7.69
  • BNZI 21.92

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.

Share on Social Networks: